|
 |
 The Egyptian International Pharmaceutical Ind.Co. :
The Egyptian International Pharmaceutical Industries Co.”EIPICO” was estsablished in 1982 as a private company according to investment Law by
a consortium consisting of local Public Sector companies and ACDIMA (Arab Co. for Drug Industries and Medical Appliances).
The Company was located in the Tenth of Ramadan City- Industrial Zone (35 KM from Cairo Airport).
From the beginning, the company was planned to formulate dosage forms of generic drugs from local and imported intermediates, applying the latest GMP regulations throughout the operational or line departments beginning with evaluation of raw materials, calibration of equipment’s and control, holding and distribution of finished products to assure quality, effectiveness and safety.
EIPICO managed to build up a place among multinationals and private companies until it became the largest pharmaceutical company in Egypt commanding an 8% of local market share and nearly 25% contribution of Egyptian Exports of drugs.
EIPICO production covered all dosage forms, the traditional such as tablets, capsules, emulsions and vials .etc. as well as non- traditional forms such as the soft gelatin capsules , lyophilized products , gels, sprayers and effervescent tablets.
EIPICO produces new dosage forms that have never been produced in Egypt before like the spansule capsules.
EIPICO is unique by its sterile areas which are insulated with laminar airflow to obtain filtered air particulate free. The critical processes are carried out in class 100 area with hepa filtered air system.
The design of EIPICO’s manufacturing facilities is considered the latest in pharmaceutical industry. The U- Shape design of the plant minimizes mix-up / contamination by providing a single direction of materials flow.
Each pharmaceutical process has enough space to be carried out apart to avoid mix-up and /or cross contamination.
EIPICO erected three sterile areas which are the largest in the MENA Region; it is currently accredited to the 1SO-9001 certificate and acquired the 1SO-14001 certificate regarding implementing environmental friendly practices.
The shareholdings structure was changed since 1995 as the public sector companies has eliminated their stake as part of the privatization program.
Currently the company has a share capital of 42 Million LE divided on 4.2 Million shares with a nominal value of 10 LE
.
|
| The ownership structure was changed as shown below: |
|
|
|
|
|
|
|
| Item |
1986 |
1998 |
| |
% |
% |
| ACDIMA (Arab
Company for |
30.00 |
27.1 |
| Drug
Industries Medical Appliances) |
|
|
| Public Sector
Pharmaceutical Companies |
70.00 |
--- |
| Medical Union
Syndicate Inv. Co. |
00.00 |
3.5 |
| Employees and
Employees Fund |
00.00 |
5.9 |
| Local Banks
and Insurance Company |
00.00 |
40.4 |
| Other
shareholders (including Foreign And |
|
|
| Local Funds
& Arab Investors) |
00.00 |
23.1 |
| Total |
100.00 |
100.00 |
|
|
Home
